The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence.

Gmeiner, William H; Debinski, Waldemar; Milligan, Carol; Caudell, David; Pardee, Timothy S

Gmeiner, William H; Debinski, Waldemar; Milligan, Carol; Caudell, David; Pardee, Timothy S.

Afiliação

Gmeiner WH; Wake Forest Baptist Medical Center Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Debinski W; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Milligan C; Wake Forest Baptist Medical Center Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Caudell D; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Pardee TS; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Future Oncol ; 12(17): 2009-20, 2016 Sep.

Article em En | MEDLINE | ID: mdl-27279153

Assuntos

Antineoplásicos/farmacologia; Fluordesoxiuridilato/análogos & derivados; Neoplasias/tratamento farmacológico; Animais; Fluordesoxiuridilato/farmacologia; Humanos

Palavras-chave

acute leukemia; cancer chemotherapy; fluoropyrimidine; glioblastoma; prostate cancer; thymineless death; topoisomerase

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluordesoxiuridilato / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Future Oncol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google